RitaAssiMD

Hematologic Oncology

Assistant Professor of Medicine

Dr. Assi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

47 citations
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
Daniel A Pollyea, Jessica K Altman, Rita Assi, Dale Bixby, Amir T Fathi
Journal of the National Comprehensive Cancer Network. 2023-05-01
6 citations
Sarcopenia Predicts Inferior Progression-Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation.
Nuttavut Sumransub, Qing Cao, Mark Juckett, Brian Betts, Shernan Holtan
Transplantation and Cellular Therapy. 2023-04-01
1 citations
Diagnostic Yield of Endobronchial Ultrasound-Guided Mediastinal Lymph Node Transbronchial Forceps Biopsies (EBUS-TBFB).
Khalil Diab, Christy Costanian, Marvi Bikak, Nawar Al Nasrallah, Ahmad A Al-Hader
Southern Medical Journal. 2023-02-01

Abstracts/Posters

Sequencing of Circulating Cell-Free DNA in Patients with AML Detects Clinically Significant Mutations Not Detected in Bone Marrow: The Role for Complementary Periphera...
Rita Assi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Final Results of Phase I/II Study of Selinexor (SEL) with Sorafenib in Patients (pts) with Relapsed and/or Refractory (R/R) FLT3 Mutated Acute Myeloid Leukemia (AML)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Impact of Clonal Hematopoiesis of Indeterminate Potential (CHIP) Associated Mutations and Risk of Comorbidities in Patients with Myelodysplastic Syndrome
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Diverse Landscape of TET2 Variants in MDS and AML
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018